1. Home
  2. DDS vs ABVX Comparison

DDS vs ABVX Comparison

Compare DDS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$626.58

Market Cap

9.2B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$139.31

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
ABVX
Founded
1938
2013
Country
United States
France
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DDS
ABVX
Price
$626.58
$139.31
Analyst Decision
Sell
Strong Buy
Analyst Count
3
12
Target Price
$511.33
$115.83
AVG Volume (30 Days)
140.4K
1.8M
Earning Date
11-13-2025
08-11-2025
Dividend Yield
5.09%
N/A
EPS Growth
N/A
N/A
EPS
36.93
N/A
Revenue
$6,625,563,000.00
$6,231,374.00
Revenue This Year
$0.60
$6.80
Revenue Next Year
N/A
N/A
P/E Ratio
$16.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$282.24
$4.77
52 Week High
$741.98
$139.62

Technical Indicators

Market Signals
Indicator
DDS
ABVX
Relative Strength Index (RSI) 43.08 66.74
Support Level $602.75 $108.53
Resistance Level $663.58 $138.49
Average True Range (ATR) 27.22 7.32
MACD -10.47 0.89
Stochastic Oscillator 17.00 91.28

Price Performance

Historical Comparison
DDS
ABVX

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: